...
首页> 外文期刊>Tropical Medicine and International Health: TM and IH >Genetic variability in Plasmodium vivax aldolase gene in Korean isolates and the sensitivity of the Binax Now malaria test.
【24h】

Genetic variability in Plasmodium vivax aldolase gene in Korean isolates and the sensitivity of the Binax Now malaria test.

机译:韩国分离株间日疟原虫间质醛缩酶基因的遗传变异性和Binax Now疟疾测试的敏感性。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Introduction of rapid malaria diagnostic tests (RDT) initiated numerous field evaluations in various epidemiologic settings. But the efficiency of some RTD kits based on aldolase raised reservations for direct implementation of RDT into clinical settings. We performed Binax Now malaria test in 84 Korean Plasmodium vivax isolates and compared it with the traditional Giemsa stain microscopy test as the reference standard. The sensitivity of Binax Now was 62.0% for P. vivax cases (52/84, 95% CI 51.2-71.6%) with 100.0% specificity (50/50, 95% confidence interval 92.9-100%). After the aldolase gene sequence analysis of 84 isolates, two synonymous mutations in aldolase gene were identified in both Binax Now positive and negative samples. No significant association between the mutations and Binax Now malaria tests was found. Thus, the genetic variability would not explain the poor performance of P. vivax RDTs by detecting aldolase in ROK isolates.
机译:快速疟疾诊断测试(RDT)的引入在各种流行病学背景下启动了许多现场评估。但是某些基于醛缩酶的RTD试剂盒的效率提高了将RDT直接应用于临床的保留。我们在84个韩国间日疟原虫分离株中进行了Binax Now疟疾测试,并将其与传统的Giemsa染色显微镜测试作为参考标准进行了比较。 Binax Now对间日疟原虫的敏感性为62.0%(52/84,95%CI 51.2-71.6%),特异性为100.0%(50/50,95%置信区间92.9-100%)。在对84个分离株的醛缩酶基因序列进行分析后,在Binax Now阳性和阴性样品中均鉴定出醛缩酶基因的两个同义突变。没有发现突变与Binax Now疟疾测试之间有显着关联。因此,遗传变异性不能通过检测韩国分离株中的醛缩酶来解释间日疟原虫RDT的不良性能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号